Combination of the bioreductive drug tirapazamine with the chemotherapeutic prodrug cyclophosphamide for P450/P450-reductase-based cancer gene therapy.
Year: 2000
Type: article
Source: PubMed
Authors: Y Jounaidi, D J Waxman
Institution: Boston University
Language: English
Subfield: Genetics
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2101041918
